Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Brussels
Clinical trial register · Belgium

Clinical Trials in Brussels, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Brussels 17 Leuven 13 Ghent 9 Edegem 9 Bonheiden 6
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Brussels

17 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Recruiting
Novo Nordisk A/S
Phase 3
450
Alken, Bonheiden, Brussels, Ghent, Kluisbergen
2026-08-12
Active, closed
Pfizer
Phase 1
57
Brussels
2026-07-23
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Alken, Brussels, Kluisbergen, La Louvière, Mechelen, Roeselare, Zwalm
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Brussels, Edegem, Ghent, Leuven, Mechelen, Roeselare
2026-02-24
Recruiting
Eli Lilly and Company
Phase 3
900
Bonheiden, Brussels, Genk, Ieper, Kortrijk, Leuven, Mechelen, Ostend
2026-02-10
Recruiting
Novo Nordisk A/S
Phase 3
460
Brussels, Edegem
2026-01-08
Active, closed
Amgen
Phase 3
12,800
Aalst, Bonheiden, Bruges, Brussels, Edegem, Genk, Ghent, La Louvière
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Aalst, Brussels, Dendermonde, Genk, Ghent, Hasselt, Herentals, Kortrijk
2025-06-25
Active, closed
Novo Nordisk A/S
Phase 3
400
Brussels, Edegem, Leuven, Mons
2025-02-10
Recruiting
Eli Lilly and Company
Phase 3
125
Brussels, Leuven
2024-11-18
Active, closed
Novo Nordisk A/S
Phase 3
212
Brussels, Edegem, Leuven
2023-07-07
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bonheiden, Boussu, Brussels, Edegem, Ghent, Leuven, Mons
2022-11-01
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aalst, Bonheiden, Brussels, Edegem, Ghent, Hasselt, Leuven, Ostend
2022-10-11
Recruiting
Centre Hospitalier Universitaire Saint Pierre
Observational
60
Brussels
2022-04-22
Active, closed
Novo Nordisk A/S
Phase 3
78
Brussels, Leuven
2021-03-04
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/brussels

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Brussels that also match the filters currently applied.

How many clinical trials are recruiting in Brussels?

9 of the 17 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brussels), 17 studies
PhaseStudiesRecruitingShare
Phase 314882.4%
Observational115.9%
Phase 1105.9%
Phase 4105.9%

Most active sponsors

Lead sponsors with the most studies (Brussels)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S94
Eli Lilly and Company43
Amgen21
Centre Hospitalier Universitaire Saint Pierre11
Pfizer10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.